Harvard Bioscience (HBIO) Net Margin (2010 - 2026)
Harvard Bioscience (HBIO) reported Net Margin of 16.5% for Q1 2026, up 21448.0% year-over-year from N/an in Q1 2025, and down 15.17% on a QoQ basis from 14.32% in Q4 2025.
Harvard Bioscience (HBIO) has 16 years of Net Margin data on file, last reported at 16.5% in Q1 2026.
- Quarterly Net Margin rose 21448.0% year-over-year to 16.5% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12.09% (up 5133.0% YoY) and the FY2025 annual result came in at 66.15%, down 5297.0% from the prior year.
- Net Margin eased to 16.5% in Q1 2026 per HBIO's latest filing, from 14.32% in the prior quarter.
- Across five years, Net Margin topped out at 8.34% in Q2 2022 and bottomed at 230.98% in Q1 2025.
- The 5-year median for Net Margin is 11.16% (2025), against an average of 22.36%.
- The widest annual swing landed in 2025, when Net Margin sank 21183 bps; it then jumped 21448 bps in 2026.
- Tracing HBIO's Net Margin over 5 years: stood at 7.61% in 2022, then climbed by 26 bps to 5.65% in 2023, then surged by 101 bps to 0.07% in 2024, then sank by 19642 bps to 14.32% in 2025, then fell by 15 bps to 16.5% in 2026.
- Per Business Quant, the three latest HBIO Net Margin figures stand at 16.5% (Q1 2026), 14.32% (Q4 2025), and 5.98% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 29.81% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -5.81% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 27.86% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 16.03% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 0.65% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 12.77% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 10.84% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 0.07% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 7.40% |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | -16.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.50% |
| Dec 31, 2025 | -14.32% |
| Sep 30, 2025 | -5.98% |
| Jun 30, 2025 | -11.16% |
| Mar 31, 2025 | -230.98% |
| Dec 31, 2024 | 0.07% |
| Sep 30, 2024 | -21.86% |
| Jun 30, 2024 | -12.47% |
| Mar 31, 2024 | -19.15% |
| Dec 31, 2023 | -5.65% |
| Sep 30, 2023 | -4.89% |
| Jun 30, 2023 | -3.41% |
| Mar 31, 2023 | 2.08% |
| Dec 31, 2022 | -7.61% |
| Sep 30, 2022 | -12.65% |
| Jun 30, 2022 | 8.34% |
| Mar 31, 2022 | -24.04% |
| Dec 31, 2021 | 1.78% |
| Sep 30, 2021 | -0.57% |
| Jun 30, 2021 | -1.48% |
| Mar 31, 2021 | -2.48% |
| Dec 31, 2020 | -2.29% |
| Sep 30, 2020 | -4.64% |
| Jun 30, 2020 | -6.78% |
| Mar 31, 2020 | -19.00% |
| Dec 31, 2019 | 1.78% |
| Dec 31, 2018 | -1.31% |
| Jun 30, 2018 | 0.11% |
| Mar 31, 2018 | 6.67% |
| Dec 31, 2017 | 4.67% |
| Sep 30, 2017 | 1.22% |
| Jun 30, 2017 | 1.24% |
| Mar 31, 2017 | -1.79% |
| Dec 31, 2016 | -5.00% |
| Sep 30, 2016 | -6.55% |
| Jun 30, 2016 | -2.73% |
| Mar 31, 2016 | -2.36% |
| Dec 31, 2015 | -60.42% |
| Sep 30, 2015 | -3.29% |
| Jun 30, 2015 | 1.21% |
| Mar 31, 2015 | -5.44% |
| Dec 31, 2013 | -1.80% |
| Sep 30, 2013 | -3.72% |
| Jun 30, 2013 | -1.08% |
| Mar 31, 2013 | -3.20% |
| Dec 31, 2012 | -7.52% |
| Dec 31, 2011 | 2.54% |
| Sep 30, 2011 | 0.11% |
| Jun 30, 2011 | 5.05% |
| Mar 31, 2011 | 6.37% |
| Dec 31, 2010 | -15.79% |
| Sep 30, 2010 | 48.12% |
| Jun 30, 2010 | 7.27% |